Business Description
Dicot AB
ISIN : SE0011178458
Compare
Compare
Traded in other countries / regions
DICOT.SwedenKN0.GermanyDCOIF.USA IPO Date
2019-09-05Description
Dicot AB is engaged in developing drugs against sexual dysfunction in Sweden. Its important products are Libiguin which is used for the treatment of erectile dysfunction and premature ejaculation in men, as well as potentially also for the treatment of decreased lust.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.83 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 45.7 | |||||
| 3-Year EPS without NRI Growth Rate | 41.7 | |||||
| 3-Year FCF Growth Rate | 43.8 | |||||
| 3-Year Book Growth Rate | -42.6 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.84 | |||||
| Quick Ratio | 5.47 | |||||
| Cash Ratio | 5.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -128.3 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -114.52 | |||||
| ROA % | -98.53 | |||||
| ROIC % | -961.79 | |||||
| ROC (Joel Greenblatt) % | -259358.82 | |||||
| ROCE % | -114.35 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 4.41 | |||||
| Price-to-Tangible-Book | 4.65 | |||||
| EV-to-EBIT | -3.34 | |||||
| EV-to-EBITDA | -3.34 | |||||
| EV-to-FCF | -3.26 | |||||
| Price-to-Net-Current-Asset-Value | 4.65 | |||||
| Price-to-Net-Cash | 4.65 | |||||
| Earnings Yield (Greenblatt) % | -29.94 | |||||
| FCF Yield % | -23.24 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with GREY:DCOIF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Dicot AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 0 - 0.47 | ||
| Shares Outstanding (Mil) | 43.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Dicot AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Dicot AB Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Dicot AB Frequently Asked Questions
What is Dicot AB(DCOIF)'s stock price today?
The current price of DCOIF is $0.47. The 52 week high of DCOIF is $0.47 and 52 week low is $0.00.
When is next earnings date of Dicot AB(DCOIF)?
The next earnings date of Dicot AB(DCOIF) is 2024-05-06.
Does Dicot AB(DCOIF) pay dividends? If so, how much?
Dicot AB(DCOIF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers